Jeffery M. Klco

10.1k total citations · 1 hit paper
85 papers, 3.2k citations indexed

About

Jeffery M. Klco is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jeffery M. Klco has authored 85 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 54 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Jeffery M. Klco's work include Acute Myeloid Leukemia Research (57 papers), Acute Lymphoblastic Leukemia research (15 papers) and Protein Degradation and Inhibitors (11 papers). Jeffery M. Klco is often cited by papers focused on Acute Myeloid Leukemia Research (57 papers), Acute Lymphoblastic Leukemia research (15 papers) and Protein Degradation and Inhibitors (11 papers). Jeffery M. Klco collaborates with scholars based in United States, Singapore and Canada. Jeffery M. Klco's co-authors include William G. Kaelin, Thomas Baranski, Andrew L. Kung, David M. Livingston, Charles G. Mullighan, Tamara Lamprecht, Kirk Narzinski, Timothy J. Ley, Nicholas G. Nickols and Peter B. Dervan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jeffery M. Klco

80 papers receiving 3.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of tumor growth through disruption of hypoxia-inducible transcription

2000 436 citations Jeffery M. Klco, William G. Kaelin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffery M. Klco United States	28	2.0k	1.2k	842	495	464	85	3.2k
Josée Hébert Canada	33	2.2k 1.1×	947 0.8×	389 0.5×	550 1.1×	443 1.0×	93	3.1k
Tracy Chaplin United Kingdom	35	2.2k 1.1×	1.1k 0.9×	937 1.1×	581 1.2×	260 0.6×	80	3.9k
Hanna S. Radomska United States	29	2.4k 1.2×	1.6k 1.3×	546 0.6×	455 0.9×	866 1.9×	58	3.7k
Jan Jacob Schuringa Netherlands	39	2.1k 1.0×	1.8k 1.5×	570 0.7×	884 1.8×	918 2.0×	147	4.1k
Tim C. P. Somervaille United Kingdom	29	3.3k 1.6×	1.7k 1.5×	435 0.5×	654 1.3×	368 0.8×	105	4.4k
John F. Lyons United States	32	2.7k 1.3×	577 0.5×	551 0.7×	1.3k 2.7×	347 0.7×	81	4.3k
Michael G. Kharas United States	36	4.2k 2.1×	1.1k 0.9×	1.6k 1.9×	713 1.4×	613 1.3×	77	5.6k
Ulrich Steidl United States	40	2.5k 1.2×	2.1k 1.8×	507 0.6×	810 1.6×	1.1k 2.5×	126	4.7k
Ignacio Varela Spain	23	2.4k 1.2×	599 0.5×	569 0.7×	386 0.8×	235 0.5×	54	3.3k
Norihiko Kawamata Japan	38	2.2k 1.1×	745 0.6×	588 0.7×	1.4k 2.7×	467 1.0×	96	4.0k

Countries citing papers authored by Jeffery M. Klco

Since Specialization

Citations

This map shows the geographic impact of Jeffery M. Klco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffery M. Klco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffery M. Klco more than expected).

Fields of papers citing papers by Jeffery M. Klco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffery M. Klco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffery M. Klco. The network helps show where Jeffery M. Klco may publish in the future.

Co-authorship network of co-authors of Jeffery M. Klco

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffery M. Klco. A scholar is included among the top collaborators of Jeffery M. Klco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffery M. Klco. Jeffery M. Klco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khanlari, Mahsa, Wei Wang, Paul E. Mead, et al.. (2025). Pediatric Myeloid Neoplasms With UBTF Tandem Duplications. The American Journal of Surgical Pathology. 49(4). 353–362. 1 indexed citations

Westover, Tamara, Michael Walsh, Sherif Abdelhamed, et al.. (2025). Genomic landscape and clonal architecture in pediatric myeloid neoplasms with chromosome 7 deletions. PubMed. 2(2). 100093–100093.

Umeda, Masayuki, Yen‐Chun Liu, Seth E. Karol, & Jeffery M. Klco. (2025). Novel classification system and high-risk categories of pediatric acute myeloid leukemia. Haematologica. 110(9). 1962–1973.

Ma, Jing, Jennifer Neary, Selene C. Koo, et al.. (2024). Pediatric Erythroid Sarcoma Diagnostically Confirmed by Identification of a Recurrent NFIA::CBFA2T3 Fusion. Genes Chromosomes and Cancer. 63(6). e23251–e23251. 1 indexed citations

Wong, Jasmine C., Tamara Westover, Benjamin J. Huang, et al.. (2024). 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies. Leukemia. 38(5). 1182–1186. 1 indexed citations

Thomas, Melvin E., Michael P. Walsh, Jing Ma, et al.. (2024). Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia. Leukemia. 38(5). 991–1002. 2 indexed citations

Barajas, Juan M., Masayuki Umeda, Jing Ma, et al.. (2023). UBTF Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis. Blood. 142(Supplement 1). 838–838. 1 indexed citations

Ghonim, Mohamed A., Stefan Schattgen, Jing Ma, et al.. (2023). Identification and Functional Validation of Neoantigen-Specific T Cells in Pediatric Patients with Fusion-Derived Acute Leukemias. Blood. 142(Supplement 1). 2074–2074. 1 indexed citations

Karol, Seth E., Stanley Pounds, Jeffery M. Klco, et al.. (2023). Preliminary Safety and Efficacy of Venetoclax and Selinexor in Combination with Chemotherapy in Pediatric and Young Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia: Selclax. Blood. 142(Supplement 1). 56–56. 1 indexed citations

10.

Zoine, Jaquelyn T., Jeremy Chase Crawford, Abishek Vaidya, et al.. (2022). Engineering naturally occurring CD7− T cells for the immunotherapy of hematological malignancies. Blood. 140(25). 2684–2696. 43 indexed citations

11.

Thomas, Melvin E., Sherif Abdelhamed, Ryan Hiltenbrand, et al.. (2021). Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells. Leukemia. 35(11). 3232–3244. 33 indexed citations

12.

Wong, Jasmine C., Victoria Bryant, Tamara Lamprecht, et al.. (2018). Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight. 3(14). 69 indexed citations

13.

Wong, Terrence N., Christopher A. Miller, Jeffery M. Klco, et al.. (2015). Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML. Blood. 127(7). 893–897. 72 indexed citations

14.

Klco, Jeffery M., David H. Spencer, Chris Miller, et al.. (2014). Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia. Cancer Cell. 25(3). 379–392. 264 indexed citations

15.

Grieselhuber, Nicole R., Jeffery M. Klco, Tamara Lamprecht, et al.. (2013). Notch signaling in acute promyelocytic leukemia. Leukemia. 27(7). 1548–1557. 25 indexed citations

16.

Wartman, Lukas D., John S. Welch, Geoffrey L. Uy, et al.. (2012). Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice. PLoS ONE. 7(10). e46529–e46529. 12 indexed citations

17.

Capoccia, Benjamin J., Jochen K. Lennerz, Andrew J. Bredemeyer, et al.. (2010). Transcription factor MIST1 in terminal differentiation of mouse and human plasma cells. Physiological Genomics. 43(3). 174–186. 21 indexed citations

18.

Klco, Jeffery M., Gregory V. Nikiforovich, & Thomas Baranski. (2006). Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop. Journal of Biological Chemistry. 281(17). 12010–12019. 55 indexed citations

19.

Olenyuk, Bogdan, Guo‐Jun Zhang, Jeffery M. Klco, et al.. (2004). Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proceedings of the National Academy of Sciences. 101(48). 16768–16773. 181 indexed citations

20.

Jiang, Yide, Wen Zhang, Jeffery M. Klco, et al.. (2003). Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways.. PubMed. 1(6). 453–62. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact